You just read:

Lexicon Announces The Validation By The European Medicine Agency Of The Marketing Authorization Application For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome

News provided by

Lexicon Pharmaceuticals, Inc.

18 Jul, 2016, 16:01 ET